Ali Mona S, El-Sadek Hala M, Rageh Mahmoud A
Department of Dermatology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Clin Exp Dermatol. 2025 Jun 25;50(7):1330-1336. doi: 10.1093/ced/llaf067.
Acanthosis nigricans (AN) is a prevalent dermatological issue with numerous treatment options that are not entirely satisfactory. Topical vitamin D analogues have been found to be effective and safe for treating AN; however, other preparations of vitamin D have not, to the best of our knowledge, been studied yet.
To evaluate the safety and efficacy of intralesional vitamin D3 injection in treating pseudo-AN.
We enrolled 30 participants who had bilateral pseudo-AN of the neck. Every patient received intralesional vitamin D3 therapy on the right side of the neck and intralesional saline as a control on the left side over the course of four sessions, each spaced 1 week apart. Participants were assessed clinically 1 month after the last treatment session using the Acanthosis Nigricans Area and Severity Index (ANASI) score in addition to dermoscopic examination.
A statistically significant difference in the ANASI score was seen between the treated and control sides after treatment, with the intralesional vitamin D-treated side exhibiting a larger percentage of reduction than the control side. Intralesional vitamin D3 treatment significantly improved dermoscopic features such as cristae cutis, sulci cutis and pigmented dots compared with the placebo treatment.
Intralesional vitamin D3 is a safe and effective modality for treating pseudo-AN.
黑棘皮病(AN)是一种常见的皮肤病问题,有多种治疗选择,但都不尽如人意。局部使用维生素D类似物已被发现对治疗AN有效且安全;然而,据我们所知,其他维生素D制剂尚未得到研究。
评估皮损内注射维生素D3治疗假性AN的安全性和有效性。
我们招募了30名患有双侧颈部假性AN的参与者。每位患者在颈部右侧接受皮损内维生素D3治疗,在左侧接受皮损内注射生理盐水作为对照,共进行4个疗程,每个疗程间隔1周。在最后一个治疗疗程后1个月,除了进行皮肤镜检查外,还使用黑棘皮病面积和严重程度指数(ANASI)评分对参与者进行临床评估。
治疗后,治疗侧和对照侧的ANASI评分存在统计学上的显著差异,皮损内注射维生素D治疗侧的减少百分比高于对照侧。与安慰剂治疗相比,皮损内注射维生素D3治疗显著改善了皮肤镜特征,如皮嵴、皮沟和色素点。
皮损内注射维生素D3是治疗假性AN的一种安全有效的方法。